NHC Response to 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft 08/28/2026 Read More
NHC Comments on CMS Proposed Rule for Medicare Drug Price Negotiation Program IPAY 2029 08/17/2026 Read More
NHC Comments on Medical Device User Fee Amendments Performance Goals and Procedures for fiscal years 2028 through 2032 08/10/2026 Read More
NHC Comments on FDA – Pharmacy Compounding Advisory Committee Meeting on Bulk Drug Substances for Section 503A 07/22/2026 Read More
